Skip to main content
Clinical Trials/RBR-7q7cq8
RBR-7q7cq8
Active, not recruiting
未知

Postoperative sensitivity in composite resin restorations with prior desensitizing agent application: Randomized clinical trial

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES0 sitesMarch 16, 2020

Overview

Phase
未知
Intervention
Not specified
Conditions
Dentin sensitivity
Sponsor
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 16, 2020
End Date
TBD
Last Updated
2 years ago
Study Type
Intervention

Investigators

Sponsor
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - CAPES

Eligibility Criteria

Inclusion Criteria

  • Volunteers over 18 years old; presence of 4 class I (occlusal) or class II cavities in the molar or premolar teeth; cavities with medium or deep depth (up to 3 mm) resulting from primary caries or need for restoration replacement; teeth with pulp vitality;
  • Enamel gingival margin in class II preparations; absence of non\-carious cervical lesions in the teeth involved in the research;
  • occlusal contact with an antagonist tooth and at least one contact with an adjacent tooth;
  • Patient with good general health; do not have any contraindications for dental treatments.

Exclusion Criteria

  • Present less than 20 teeth; history of spontaneous dentinal sensitivity; periodontal disease; bruxism; teeth with impossibility of absolute isolation; teeth with pulp exposure during cavity preparation; teeth that needed pulp protection in addition to the application of the adhesive system during the restorative procedure; allergy to resinous materials; impossibility to return to reevaluation consultations; fractured or visibly cracked tooth; conducting current desensitization therapy, including desensitizing toothpastes or other desensitizing products; medical, psychiatric or pharmacotherapeutic history that may compromise the protocol, including the chronic use of anti\-inflammatory, analgesic and psychotropic drugs; pregnancy or breast\-feeding; allergies and idiosyncratic responses to the composition of the products;
  • orthodontic treatment performed within the previous three months; abutment teeth for fixed or removable prosthesis; teeth or support structures with any painful pathology;
  • periodontal surgery within the previous three months; patients under whitening treatment.

Outcomes

Primary Outcomes

Not specified

Similar Trials